The apoptosis and viability studies reported here indicate that S-NPAA treatment is effective at decreasing viability not only in LNCaP cells, but also in the tumorigenic DU145 and PC3 human prostate cancer cells, which have OPH activities similar to RWPE-1 cells (Figure 8A and B). Here, APEH is linked to prostate carcinoma.